Eli Lilly and Company (LLY)

Total asset turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	US$ in thousands	45,042,700	34,124,100	28,541,400	28,318,400	24,539,800
Total assets	US$ in thousands	78,714,900	64,006,300	49,489,800	48,806,000	46,633,100
Total asset turnover		0.57	0.53	0.58	0.58	0.53

December 31, 2024 calculation

Total asset turnover = Revenue ÷ Total assets
= $45,042,700K ÷ $78,714,900K
= 0.57

Based on the provided data, Eli Lilly and Company's total asset turnover has shown some fluctuations over the past five years. The total asset turnover ratio calculates how efficiently a company is using its assets to generate revenue. A higher ratio indicates that the company is generating more revenue per dollar of assets.

In 2020, Eli Lilly's total asset turnover was 0.53, which indicates that for every dollar of assets they had, they generated $0.53 in revenue. Over the following years, the ratio increased to 0.58 by the end of 2021 and remained at the same level at the end of 2022. This suggests that the company's efficiency in utilizing its assets to generate revenue improved during these years.

However, in 2023, the total asset turnover decreased back to 0.53, indicating a potential decrease in revenue generated per dollar of assets. By the end of 2024, the ratio showed a slight improvement, reaching 0.57.

Overall, the trend in Eli Lilly's total asset turnover suggests fluctuations in the company's efficiency in generating revenue from its assets. It would be important to further investigate the factors contributing to these fluctuations to assess the company's operational performance and asset utilization strategy accurately.